Our results also showed that overexpression of PLPP4 promoted the invasiveness of glioma LN229 cells, while the number of cells in the shRNA-PLPP4 group was reduced, and the invasiveness was reduced by 55.2% through the transwell assay (Figure 8H). Here, PLPP4 is linked to central nervous system cancer.